The Asia Pacific Cardiovascular Digital Solutions Market should witness market growth of 5.8% CAGR during the forecast period (2022-2028).
The cardiac digital provider ecosystem is changing as a result of digital convergence. Reducing hospital admissions and changing care delivery paradigms are two examples of this. If cardiovascular digital solutions offer more than simply devices and give healthcare professionals and patients data-driven, clinically relevant, and actionable information, they will be competitive. The top cardiac monitoring providers will keep expanding and providing complete portfolios that include service and product solutions.
As a result, all cardiovascular performance management,clinical pathways, and other associated services will be accessible through a single portal, the cardiovascular information system (CVIS). Cloud-based CVIS applications will expand significantly in the future. They can enable comprehensive pathway management among all patient pathways by easily integrating with hospitals' existing corporate architectures. In addition to the current cardiac data analytics frameworks, including AIcapabilities to support clinical decisions will encourage CVD prevention and treatment to the intended outcomes-based regime.
Given that Asia is home to half of the world's population, the management of cardiovascular disease (CVD) in the Asia Pacific region is an important public health concern. The Kingdom of Thailand, Japan, South Korea, Hong Kong, and other Asian countries and regions are known for having a higher morbidity and mortality rate from strokes than from coronary heart disease (CHD). Ischemic heart disorder(IHD)and stroke are the most common causes of CVD in Asia Pacific and account for more than half of all cardiovascular-relateddeaths in the region, mainly in Central, Western, & Southern Asia. Such high numbers have prompted regional governments to develop superior healthcare infrastructure, including technological solutions and other interventions.
The China market dominated the Asia Pacific Cardiovascular Digital Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $9,732.8 Million by 2028. The Japan market is estimated to grow a CAGR of 5.1% during (2022-2028). Additionally, The India market would experience a CAGR of 6.4% during (2022-2028).
Based on Service Type, the market is segmented into Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs and Others. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers and Others. Based on Deployment, the market is segmented into Cloud-Based and On-premise. Based on Components, the market is segmented into Devices and Software. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Apple, Inc., General Electric Company, Koninklijke Philips N.V., Verily Life Sciences LLC (Alphabet, Inc.), iRhythm Technologies, Inc., Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.), eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation), AliveCor, Inc., Cardiotrack, and HeartFlow, Inc.
The cardiac digital provider ecosystem is changing as a result of digital convergence. Reducing hospital admissions and changing care delivery paradigms are two examples of this. If cardiovascular digital solutions offer more than simply devices and give healthcare professionals and patients data-driven, clinically relevant, and actionable information, they will be competitive. The top cardiac monitoring providers will keep expanding and providing complete portfolios that include service and product solutions.
As a result, all cardiovascular performance management,clinical pathways, and other associated services will be accessible through a single portal, the cardiovascular information system (CVIS). Cloud-based CVIS applications will expand significantly in the future. They can enable comprehensive pathway management among all patient pathways by easily integrating with hospitals' existing corporate architectures. In addition to the current cardiac data analytics frameworks, including AIcapabilities to support clinical decisions will encourage CVD prevention and treatment to the intended outcomes-based regime.
Given that Asia is home to half of the world's population, the management of cardiovascular disease (CVD) in the Asia Pacific region is an important public health concern. The Kingdom of Thailand, Japan, South Korea, Hong Kong, and other Asian countries and regions are known for having a higher morbidity and mortality rate from strokes than from coronary heart disease (CHD). Ischemic heart disorder(IHD)and stroke are the most common causes of CVD in Asia Pacific and account for more than half of all cardiovascular-relateddeaths in the region, mainly in Central, Western, & Southern Asia. Such high numbers have prompted regional governments to develop superior healthcare infrastructure, including technological solutions and other interventions.
The China market dominated the Asia Pacific Cardiovascular Digital Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $9,732.8 Million by 2028. The Japan market is estimated to grow a CAGR of 5.1% during (2022-2028). Additionally, The India market would experience a CAGR of 6.4% during (2022-2028).
Based on Service Type, the market is segmented into Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs and Others. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers and Others. Based on Deployment, the market is segmented into Cloud-Based and On-premise. Based on Components, the market is segmented into Devices and Software. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Apple, Inc., General Electric Company, Koninklijke Philips N.V., Verily Life Sciences LLC (Alphabet, Inc.), iRhythm Technologies, Inc., Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.), eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation), AliveCor, Inc., Cardiotrack, and HeartFlow, Inc.
Scope of the Study
By Service Type
- Unobtrusive Testing
- CVD Health Informatics
- Cardiac Rehab Programs
- Others
By End-use
- Hospitals & Clinics
- Ambulatory Care Centers
- Others
By Deployment
- Cloud-Based
- On-premise
By Components
- Devices
- Software
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Apple, Inc.
- General Electric Company
- Koninklijke Philips N.V.
- Verily Life Sciences LLC (Alphabet, Inc.)
- iRhythm Technologies, Inc.
- Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.)
- eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
- AliveCor, Inc.
- Cardiotrack
- HeartFlow, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Cardiovascular Digital Solutions Market, by Service Type
1.4.2 Asia Pacific Cardiovascular Digital Solutions Market, by End-use
1.4.3 Asia Pacific Cardiovascular Digital Solutions Market, by Deployment
1.4.4 Asia Pacific Cardiovascular Digital Solutions Market, by Components
1.4.5 Asia Pacific Cardiovascular Digital Solutions Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Analyst's Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Aug - 2022, Nov) Leading Players
Chapter 4. Asia Pacific Cardiovascular Digital Solutions Market by Service Type
4.1 Asia Pacific Unobtrusive Testing Market by Country
4.2 Asia Pacific CVD Health Informatics Market by Country
4.3 Asia Pacific Cardiac Rehab Programs Market by Country
4.4 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Cardiovascular Digital Solutions Market by End-use
5.1 Asia Pacific Hospitals & Clinics Market by Country
5.2 Asia Pacific Ambulatory Care Centers Market by Country
5.3 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Cardiovascular Digital Solutions Market by Deployment
6.1 Asia Pacific Cloud-Based Market by Country
6.2 Asia Pacific On-premise Market by Country
Chapter 7. Asia Pacific Cardiovascular Digital Solutions Market by Components
7.1 Asia Pacific Devices Market by Country
7.2 Asia Pacific Software Market by Country
Chapter 8. Asia Pacific Cardiovascular Digital Solutions Market by Country
8.1 China Cardiovascular Digital Solutions Market
8.1.1 China Cardiovascular Digital Solutions Market by Service Type
8.1.2 China Cardiovascular Digital Solutions Market by End-use
8.1.3 China Cardiovascular Digital Solutions Market by Deployment
8.1.4 China Cardiovascular Digital Solutions Market by Components
8.2 Japan Cardiovascular Digital Solutions Market
8.2.1 Japan Cardiovascular Digital Solutions Market by Service Type
8.2.2 Japan Cardiovascular Digital Solutions Market by End-use
8.2.3 Japan Cardiovascular Digital Solutions Market by Deployment
8.2.4 Japan Cardiovascular Digital Solutions Market by Components
8.3 India Cardiovascular Digital Solutions Market
8.3.1 India Cardiovascular Digital Solutions Market by Service Type
8.3.2 India Cardiovascular Digital Solutions Market by End-use
8.3.3 India Cardiovascular Digital Solutions Market by Deployment
8.3.4 India Cardiovascular Digital Solutions Market by Components
8.4 South Korea Cardiovascular Digital Solutions Market
8.4.1 South Korea Cardiovascular Digital Solutions Market by Service Type
8.4.2 South Korea Cardiovascular Digital Solutions Market by End-use
8.4.3 South Korea Cardiovascular Digital Solutions Market by Deployment
8.4.4 South Korea Cardiovascular Digital Solutions Market by Components
8.5 Singapore Cardiovascular Digital Solutions Market
8.5.1 Singapore Cardiovascular Digital Solutions Market by Service Type
8.5.2 Singapore Cardiovascular Digital Solutions Market by End-use
8.5.3 Singapore Cardiovascular Digital Solutions Market by Deployment
8.5.4 Singapore Cardiovascular Digital Solutions Market by Components
8.6 Malaysia Cardiovascular Digital Solutions Market
8.6.1 Malaysia Cardiovascular Digital Solutions Market by Service Type
8.6.2 Malaysia Cardiovascular Digital Solutions Market by End-use
8.6.3 Malaysia Cardiovascular Digital Solutions Market by Deployment
8.6.4 Malaysia Cardiovascular Digital Solutions Market by Components
8.7 Rest of Asia Pacific Cardiovascular Digital Solutions Market
8.7.1 Rest of Asia Pacific Cardiovascular Digital Solutions Market by Service Type
8.7.2 Rest of Asia Pacific Cardiovascular Digital Solutions Market by End-use
8.7.3 Rest of Asia Pacific Cardiovascular Digital Solutions Market by Deployment
8.7.4 Rest of Asia Pacific Cardiovascular Digital Solutions Market by Components
Chapter 9. Company Profiles
9.1 Apple, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 General Electric Company
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.5.3 Acquisition and Mergers:
9.3 Koninklijke Philips N.V.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.4 Verily Life Sciences LLC (Alphabet, Inc.)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 iRhythm Technologies, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Research & Development Expense
9.6 Bardy Diagnostics, Inc.(Hill-Rom Holdings Inc)(Baxter International Inc.)
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Product Launches and Product Expansions:
9.7 eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.8 AliveCor, Inc.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Partnerships, Collaborations, and Agreements:
9.8.2.2 Product Launches and Product Expansions:
9.9 Cardiotrack
9.9.1 Company Overview
9.10. HeartFlow, Inc.
9.10.1 Company Overview
Companies Mentioned
- Apple, Inc.
- General Electric Company
- Koninklijke Philips N.V.
- Verily Life Sciences LLC (Alphabet, Inc.)
- iRhythm Technologies, Inc.
- Bardy Diagnostics, Inc.(Hill-Rom Holdings Inc)(Baxter International Inc.)
- eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
- AliveCor, Inc.
- Cardiotrack
- HeartFlow, Inc.
Methodology
LOADING...
